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The goal of this study was to define Na,K-ATPase α and β subunit isoform expression and
isozyme composition in colorectal cancer cells and liver metastases. The α1, α3, and β1
isoforms were the most highly expressed in tumor cells and metastases; in the plasma
membrane of non-neoplastic cells and mainly in a cytoplasmic location in tumor cells.
α1β1 and α3β1 isozymes found in tumor and metastatic cells exhibit the highest and
lowest Na+ affinity respectively and the highest K+ affinity. Mesenchymal cell isozymes
possess an intermediate Na+ affinity and a low K+ affinity. In cancer, these ions are
likely to favor optimal conditions for the function of nuclear enzymes involved in mitosis,
especially a high intra-nuclear K+ concentration. A major and striking finding of this study
was that in liver, metastasized CRC cells express the α3β1 isozyme. Thus, the α3β1
isozyme could potentially serve as a novel exploratory biomarker of CRC metastatic cells
in liver.
Keywords: Na/K-ATPase isozymes, sodiumpump isozymes, colorectal cancer, colorectal cancer livermetastases,
Na/K-ATPase isoforms colorectal cancer immunohistochemistry
INTRODUCTION
Colorectal cancer (CRC) is one of the major causes of neoplasia-related morbidity and mortality,
representing the second major cause of disease incidence among females and the third among
males (Jemal et al., 2011). In the western world, CRC is the 4th leading cause of death (Ferlay
et al., 2010). Metastatic CRC cells can invade, populate and flourish in a new niche and ultimately
cause organ dysfunction and death. CRC spawns metastases in liver, lungs, bone marrow and brain
(Chiang and Massague, 2008). However, it is the liver where CRC cells metastasize most frequently
(Hess et al., 2006). The first line treatment for CRC involves surgery and adjuvant oxaliplatin based
chemotherapy. A common side effect of this treatment strategy is oxaliplatin-induced peripheral
neuropathy (Pachman et al., 2014).
Previous research from our group has led to the identification of several genes, which were
shown to be significantly up-, or down- regulated in peripheral white cells (PWCs) of CRC patients,
due to oxaliplatin-based chemotherapy (Morales et al., 2014). Interestingly, one of the differentially
expressed genes was the isoform α3 of the Na,K-ATPase; mRNA levels of Na,K-ATPase α3 subunit
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were down-regulated 2.6-fold. Moreover, an alteration in the
intracellular location of Na,K-ATPase α3 isoform has been
reported in humanCRC tumor cells vs. normal colon (Sakai et al.,
2004). Additionally, other laboratories have shown differential
expression in cells, altered subcellular localization and down
regulation of the β subunit of the Na+/K+-ATPase in carcinoma
cells (Rajasekaran et al., 1999, 2001a,b, 2010).
Na,K-ATPase is an integral protein in the plasma membrane
of all animal cells that transports three sodium ions out
and two potassium ions into the cell, against electrochemical
gradient (Skou, 1957; Jorgensen et al., 2003). This activity is
necessary for the regulation of the cellular ionic homeostasis
and maintaining the electrochemical gradient required for ion
channel function and secondary active transport (Mobasheri
et al., 2000). Recently, additional functions for the Na,K-ATPase
in the cell have been proposed, as a signal transducer and
transcription activator (Aizman et al., 2001; Miyakawa-Naito
et al., 2003; Harwood and Yaqoob, 2005; Yuan et al., 2005;
Zhang et al., 2006) affecting cell proliferation (Abramowitz
et al., 2003), cell motility (Barwe et al., 2005), and apoptosis
(Wang and Yu, 2005). Besides this, the Na,K-ATPase is
the receptor of cardiotonic glycosides. It is functionally
composed of catalytic α (100–112 kDa) and regulatory β
(45–55 kDa) subunit and an optional γ (6.5–10 kDa) subunit
belonging to the FXYD family of proteins (Mercer et al.,
1993).
Na,K-ATPase is expressed as several isozymes. Four different
isoforms of the α subunit have been found in humans (Blanco,
2005). The α1 isoform (ATP1A1 gene) is expressed almost in all
tissues. Isoform α2 (ATP1A2 gene) is the predominant isoform in
skeletal muscle (Hundal et al., 1992), brain (astrocytes) (McGrail
et al., 1991), heart (Zahler et al., 1992), and adipose tissue (Lytton
et al., 1985). The α3 isoform (ATP1A3 gene) is primarily found
in the brain (neurons) (Hieber et al., 1991; McGrail et al., 1991)
and isoform α4 (ATP1A4 gene) is only expressed in testis (Woo
et al., 2000). In reference to the β subunit, three different isoforms
have been identified: β1 (ATP1B1 gene), β2 (ATP1B2 gene) and
β3 (ATP1B3 gene). While β1 has a generalized expression in
almost all tissues and cells, the expression of the other β isoforms
are more restricted to certain tissues and cells. The β2 isoform
is found in skeletal muscle (Lavoie et al., 1997), pineal gland
(Shyjan et al., 1990), and nervous tissues (Peng et al., 1997),
whereas β3 is present in testis, retina, liver, and lung (Malik
et al., 1996; Zahler et al., 1996; Arystarkhova and Sweadner,
1997; Martin-Vasallo et al., 2000). The expression pattern of
the Na,K-ATPase subunit-isoforms is subjected to developmental
and hormonal regulation and can be altered during disease
(Book et al., 1994; Charlemagne et al., 1994; Charlemagne
and Swynghedauw, 1995; Ewart and Klip, 1995; Zahler et al.,
1996).
The purpose of this study was to determine the cellular
and subcellular localization of the α and β subunit isoforms
of Na,K-ATPase in CRC and its liver metastasis using a panel
of well-characterized isoform-specific antibodies. The primary
hypothesis of this study was that metastatic cancer cells possess a
unique expression phenotype of Na,K-ATPase isozymes, similar
to that of CRC cells.
MATERIALS AND METHODS
Tissue Samples
The Ethics Committee of the Universidad de La Laguna (ULL)
and Ethical Committee of the Hospital Universitario Nuestra
Señora de Candelaria (HUNSC) approved this study. All patients
signed an informed-consent document for diagnosis and research
on tissue specimen before being enrolled in the project. All the
study subjects were treated with FOLFOX CT: day 1 oxaliplatin
100mg/m2 iv over 2 h; leucovorin calcium 400mg/m2 iv over
2 h; followed by 5-fluorouracil 400mg/m2 iv bolus and by 5-
fluorouracil 2400mg/m2 iv over 46 h; every 14 days. Paraffin-
embedded tissue samples and clinical data were obtained from
15 patients (7 males, 8 females) and 1 control male from the
reference medical areas of HUNSC.
Antibodies
Table 1 shows antibodies and references used in this study.
Secondary antibodies used were goat anti-rabbit IgG or
goat anti-mouse IgG. Biotinylated secondary antibody was
used for immunohistochemistry (IHC), whereas secondary
antibodies targeted with specific fluorochromes were used for
immunofluorescence (IF).
Immunohistochemistry
Five-micron thick paraffin embedded tissue sections were
deparaffinized in xylene and hydrated in graded series of
alcohol baths. Heat mediated antigen retrieval was performed
in an autoclave at 120◦C for 10min in sodium citrate buffer
pH 6.0 before commencing the IHC staining protocol. To
remove endogenous peroxidase activity, sections were incubated
with 3% H2O2 in methanol for 15min at room temperature.
Non-specific sites were blocked with 5% Fetal Bovine Serum
(FBS), 0.3% Triton-X-100 in Tris-buffered saline (TBS) for
1 h at room temperature. Endogen biotin was blocked with
the Avidin/Biotin Vector Blocking Kit (Vector Laboratories
Inc., #SP-2001, Burlingame, CA 94010, USA) according to the
manufacturer’s instructions. Primary antibodies (see Table 1)
were incubated O/N at 4◦C. Slices were then incubated for 2 h at
37◦C with biotin-conjugated secondary antibodies (see Table 1).
Antibodies for IHC were diluted in TBS, 5% FBS, 0.1% Triton.
To amplify the specific antibody staining, ABC complex (Pierce,
Thermo Fisher Scientific Inc., #32020, Waltham, MA, USA) was
applied to the sections, prepared according to manufacturer’s
instruction and incubated for 1 h at room temperature.
3,3′-diaminobenzidine (DAB) Substrate Concentrate (Bethyl
Laboratories Inc., #.IHC-101F, Montgomery, Texas, USA) was
used to visualize immunoperoxidase activity. Slides were
counterstained with Harris Hematoxylin solution DC (Panreac,
#256991.1610 Barcelona, Spain) to visualize cell nuclei. Samples
were mounted with Eukitt (Panreac, #253681, Barcelona,
Spain) and optical light microscope (Olympus BX50, Tokyo,
Japan) was used to visualize IHC staining results. Images
were acquired using the Olympus DP70 camera and the DP
controller software 2.1.1.183 (Copyright 2001–2004 Olympus
Corporation). Negative control experiments were carried out by
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TABLE 1 | Antibodies used in this study. α1(620) (Sztul et al., 1987), α3 (Pietrini et al., 1992), α3 (XVIF9-G10) (Arystarkhova and Sweadner, 1996), SpETβ1
and SpETβ2 (Gonzalez-Martinez et al., 1994).
Antibody Target Host Type Dilution Source
α1(620) α1-isoform* R P 1:1000 M. J. Kashgarian
α3 α3-isoform* R P 1:600 M. Caplan
α3 (XVIF9-G10) α3-isoform* M Mc 1:5 Arystarkhova and Sweadner
SpETβ1 β1-isoform* R P 1:600 P. Martin-Vasallo
SpETβ2 β2-isoform* R P 1:600 P. Martin-Vasallo
Anti-proliferating cell antigen (Anti-PCNA) PCNA M Mc 1:100 Boehringer Mannheim
Anti-rabbit IgG (H+L), biotin conjugated (2◦) Rabbit-IgG G P 1:300 Pierce
Anti-rabbit IgG (whole molecule), FITC-conjugated (2◦) Rabbit-IgG G P 1:200 Sigma
Anti-mouse IgG, DyLight®650-conjugated (2◦) Mouse-IgG G P 1:100 Abcam
R, rabbit; G, goat; M, mouse; Mc, monoclonal; P, polyclonal.
*subunit-isoforms of the Na,K-ATPase, 2◦: secondary antibody.
following the procedure stated above but without incubating with
primary antibody.
Double Immunofluorescence Simultaneous
Staining
As with the IHC samples, tissue sections for IF staining were
paraffin embedded. After deparaffinization, hydration and heat-
induced epitope retrieval procedure (as described above for the
IHC staining), slides were incubated with 5%BSA, 0.3%Triton-X-
100 in TBS to block non-specific sites. Then tissue sections were
incubated simultaneously with a mixture of two distinct primary
antibodies (e.g., rabbit against human target 1 and mouse against
human target 2) overnight at 4◦C. Slices were then incubated
for 1 h at room temperature in dark with a mixture of two
secondary antibodies (see Table 1) conjugated to two different
fluorochromes (i.e., FITC-conjugated against rabbit-Sigma and
DyLight R©650-conjugated againstmouse-Abcam). Antibodies for
IF were diluted in TBS, 1% bovine serum albumin (BSA),
0.1% Triton. Slides were mounted with ProLong R©Diamond
Anti-fade Mountant with DAPI (Molecular Probes by Life
Technologies, #P36962, Eugene, Oregon, USA) to visualize
cell nuclei. Slides were acquired and analyzed using Olympus
confocal microscope (Olympus FV1000, Tokyo, Japan) and the
software FV10-ASW1.3; Lasers: Diode 405 nm, Argon multiline
458/488/514, HeNe 633 nm. Images were acquired by sequential
scan (first sequence Diode and HeNe, second sequence Argon)
to avoid overlapping of channels. Image resolution 1024× 1024.
Objective lens: 60X/1.35 NA oil Plan-Apochromat. Negative
control experiments were carried out by following the same
immunohistochemical procedure but with the primary antibody
omitted.
Image Analysis and Scoring
Samples were evaluated by two independent observers who were
blinded to the clinical data. Scores were graded as absent (−),
moderate (+) or strong (+ + +) for any specific kind of cell.
These cut-offs were established by consensus of all investigators.
For all tumors this grading was applied to three different patterns
of Na,K-ATPase α and β subunit isoform staining in tumor
cells: staining of the plasma membrane; staining of the nuclear
envelope and staining of the cytoplasm.
Final results were computed as the product of staining
intensities. In cases where scorings differed, the observers re-
evaluated samples to consensus. All samples were analyzed and
scored.
RESULTS
Na,K-ATPase α1 and α3 Isoform
Expression in CRC
In healthy colon tissue (Figures 1A,C), the α1 isoform was
detected at the basolateral side of the plasma membrane of
epithelial cells lining the colonic mucosae of Lieberkühn Crypts
and in discrete stromal cells in the connective tissue surrounding
the crypts. In turn, α1 isoform was mainly detected in a peri-
nuclear location in tumor cells (Figures 1B,D). Mesenchymal
cells from the stromal tissue surrounding the tumor also
exhibited positive immunostaining (Figures 1B,D).
The Na,K-ATPase α3 isoform was detected on epithelial cells
lining the colonic crypts and on cells from the lamina propria in
healthy colon (Figure 1E). The α3 isoform was mainly detected
in or near the plasma membrane of epithelial cells and in the
cytoplasm of positively stained cells in the stroma. In CRC tumor
samples, the α3 isoform was mainly located in a peri-nuclear
location in CRC tumor cells, while in the plasma membrane
of these cells staining was negative (Figure 1F). Stromal cells
surrounding the tumor were also α3-positive. Immunolabeling
for the α3 isoform was also detected in microvascular endothelial
cells (Figure 1H) and in cells from the inflammatory reaction
associated with CRC within the stroma (Figure 1G), where the
α3 isoform showed an intense and specific peri-nuclear labeling.
Na,K-ATPase β1 Isoform Expression in
CRC
The β1 isoform of Na,K-ATPase was detected in epithelial cells
from the normal colonic mucosae (Figure 2A). There was a high
positive staining at the baso-lateral side of polarized epithelial
cells that line the colonic Lieberkühn crypts (Figure 2B).
In CRC tumors, the β1 isoform presented a less defined
expression pattern. This isoform was detected in some tumor
cells, but the location was not well-defined, and was seen in
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FIGURE 1 | Immunolocalization of the Na,K-ATPase α1 and α3 subunit
isoforms in normal colon and colorectal cancer (CRC). (A,C) α1
immunostaining in baso-lateral side of polarized epithelial cells in healthy
colonic mucosae, black arrow. g, colonic gland (Lieberkühn crypts); mm,
muscularis mucosae; lm, lamina propia mucosae. (B,D) peri-nuclear labeling
for the α1 isoform in tumor cells. T, tumor; L, lumina; m, mesenchymal tissue.
(E) α3 immunostaining in plasma membrane of healthy colon epithelial tissue.
(F) α3 expressed peri-nuclearly in CRC tumor (arrows). (G) α3 immunostaining
in tumor cells (T) surrounded by immune cells (arrows). (H) Endothelial cells
expressing the α3 isoform in a peri-nuclear location (arrows).
several subcellular locations within the tumor. In some tumor
cells β1 staining was peri-nuclear (Figure 2C), while in others a
peripheral location was observed (Figure 2C).
In addition, in healthy tissue, β1 was detected in cells of the
myenteric plexus, also known as the Auerbach’s plexus, within the
muscular tissue of the muscularis propia (Figure 2E). In the cells
from the plexus,Na,K-ATPase β1 isoform was detected in or near
the cytoplasmic membrane of axons and dendrites of neurons
and glial cells (Figure 2F).
Na,K-ATPase β2 Isoform Expression in
CRC
The β2 isoform was detected at the baso-lateral side of polarized
epithelial cells from the normal colonic mucosae and in
FIGURE 2 | Immunolocalization of the Na,K-ATPase β1 and β2 isoforms
in normal colon and CRC. (A,B) β1 is mainly located at the baso-lateral side
of polarized epithelial cells from the normal colonic mucosae (arrows in B). (C)
β1 is located in the cytosol of tumor cells (arrows). (D) β1 is located at the cell
membrane of tumor cells (arrows). (E) Cells from the myenteric plexus (MyP) at
the muscularis propia (mp) express β1. (F) β1 isoform is mainly located in or
near the cytoplasmic membrane of the neurons and/or glia; a neuron nucleus
with visible nucleolus is indicated using an arrow. g, colonic gland (Lieberkühn
crypts); lm: lamina propia mucosae. (G) Selected cells from the connective
tissue of the mucosae express the β2 isoform (arrows). (H) β2 is mainly located
at the baso-lateral side of polarized epithelial cells from the normal colon
mucosae (arrows). (I) β2 was not detected in tumor cells from
adenocarcinomatous glands (T); however, some stroma (S) cells express β2
(arrows). (J) Possible leukocytes of the stroma expressing β2 (arrows). (K)
Cells from the myenteric plexus (MyP) at the muscularis propia (mp) express
β2. (L) β2 isoform is mainly located at the soma of glia cells (arrows).
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selected fibroblastic and immune cells from the lamina propria
(Figure 2G) and (Figure 2H). In colon adenocarcinoma cells,
the β2 isoform was not detected (Figures 2I,J). However,
some immune cells located in the stromal tissue surrounding
the tumor, were β2 positive while others remained negative
(Figures 2I,J). In immunopositive cells, β2 staining was
detected peri-nuclearly and also throughout the cytoplasm.
Immunostaining intensity for the β2 isoform varied from
strong to weak across cells in this region. In myenteric plexus
(Figure 2K) the β2 isoform was detected in the soma of neural
cells (Figure 2L).
Co-Expression of Na,K-ATpase α3 and β1
Isoforms and PCNA
In CRC, some cells from adenocarcinomatous glands showed
positive staining to both PCNA (nuclei) and Na,K-ATPase α3
isoform (cytoplasm) (Figure 3), and PCNA and β1 isoform
(plasma membrane) (Figure 3).
Na,K-ATPase α1 and α3 Isoform
Expression in CRC Metastases in Liver
In healthy liver tissue, hepatocytes were immunopositive for α1,
in the plasma membrane (Figure 4A). Bile ducts cells were also
α1 positive (Figure 4B), and the staining was detected mainly
at the baso-lateral side of the plasma membrane. In metastases,
the Na,K-ATPase α1 isoform was detected in cytoplasm and in
the cytoplasmic membrane of cells of metastatic tumor niches
(Figures 4C,D).
In normal healthy liver, Na,K-ATPase α3 isoform was not
detected in any cell types (Figure 4E). However, in metastatic
tumor cells within the liver, the α3 isoform was detected
(Figure 4F; Supplementary Figure S1D) in a peri-nuclear
location and spread across the cytoplasm. Staining intensity
varied among cells, from strong to weak labeling. In addition
to tumor cells, this isoform was also detected in immune
cells located at the outermost part of the liver (Figure 4G).
In apparently healthy liver tissue surrounding metastases,
Na,K-ATPase α3 isoform was detected peri-nuclearly and also
throughout the cytoplasm of hepatocytes (Figure 4H).
Na,K-ATPase β1 and β2 Isoforms
Expression in Metastasis
In metastasized liver, the β1 isoform was detected at the plasma
membrane of hepatocytes (Figure 5A), bile ducts epithelial cells
(Figure 5B) and peri-nuclearly and/or in the cytoplasm of cells in
disorganized and necrotic tissue (Figures 5C,D; Supplementary
Figure S1C).
In healthy liver tissue, the β2 isoform was detected in the
cytoplasm of some cells and in peri-nuclear locations in others
(Figures 5E,F), with variable staining intensities among cells
ranging from strong to weak. A weak but specific signal for the
β2 isoform was also detected in bile ducts cells at the portal
triads (Figure 5G). However, the β2 isoform was not detected in
metastatic tumor cell niches (Figure 5H).
We were unable to detect the α2 and β3 subunit isoforms
as their expression levels were probably below the threshold of
the ABC amplified immunohistochemical detection technique
employed in this study.
Na,K-ATPase α3 and β1 Isoforms
Coexpression in Metastasis
In order to further confirm the co-expression of the α3 and β1
subunits isoforms in the same metastatic cells in the liver, using
a different and monoclonal antibody, we performed confocal
microscopy co-localization experiments. Image analysis and
scoring was done using same procedure as in all other cases
FIGURE 3 | Double immunofluorescence localization of Na,K-ATPase α3 and β1 isoform and proliferating cell nuclear antigen (PCNA) in CRC. Left
panel: (A) α3 isoform is expressed in colon tumor cells (green). (B) High numbers of tumor cells express PCNA (red). (C) The tumor cells express both PCNA and the
α3 isoform (blue and green merged). (D) α3 isoform is mainly located internally at the cytoplasm; blue (DAPI), red (PCNA), and green (α3 isoform) merged image. L,
lumina. Right panel: (E) β1 isoform is expressed in colonic tumor cells (green). (F) High number of tumor cells expresses PCNA (red). (G) The tumor cells express both
PCNA and β1 isoform (red and green merged). (H) Blue (DAPI), red (PCNA), and green (β1 isoform) merged image.
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FIGURE 4 | Immunolocalization of the Na,K-ATPase α1 and α3 isoforms
in normal liver and liver metastasis. (A) α1 isoform is located at the plasma
membrane of the hepatocytes (arrows). (B) Bile duct epithelial cells (B) express
α1 isoform, mainly at the baso-lateral side of cell membrane. (C) α1 isoform is
located at the cytosol of metastatic tumor cells (arrows). (D) α1 is present at a
peripheral position in metastatic tumor cells (arrows). (E) Negative
immunolocalization of the α3 isoform in normal liver tissue. (F) α3 isoform is
mainly located at a peri-nuclear position but also detected all-over the
cytoplasm. (G) Inflammatory reaction established at the outermost part of the
liver; α3 IHC-positive cells may correspond to cells from the immune system
(arrows), such as leukocytes. (H) In normal liver tissue from a metastasized
liver, hepatocytes express α3 in peri-nuclear and cytoplasmic locations.
and stated in the Materials and Methods section. As shown in
Figure 6 and in Supplementary Figure S1, both of them co-
localize in a number of metastatic cells in percentages ranging
from+ to+++, depending on the sample and on the area within
the same sample. Most of them showed further more than 2/3 of
total metastatic cells.
DISCUSSION
In this study we explored the cellular and subcellular localization
of the α and β subunit isoforms of Na,K-ATPase in CRC
and its liver metastases. The aim of this work was to test
the hypothesis that metastatic cancer cells possess a unique
FIGURE 5 | Immunolocalization of the Na,K-ATPase β1 and β2 isoforms
in normal liver tissue and liver metastasis. (A) β1 isoform is mainly located
at the cytoplasmic membrane of hepatocytes (arrows) from normal liver. (B)
Bile duct epithelial cells (B) express β1, V, venule. (C) Nuclei of metastatic
tumor cells (arrows). (D) β1 IHC-positive staining at necrotic tissue is signaled
with arrows; S, septum. (E) β2 is differentially expressed at the cytoplasm of
neighboring hepatocytes (arrows) of normal liver. (F) Hepatocytes with different
degrees of β2 immunostaining at a peri-nuclear position in neighboring
hepatocytes (arrows) of normal liver. (G) In normal liver, a bile duct (B) and cells
from the lining connective tissue (arrow) express β2. (H) Metastatic tumor cells
(T) do not express β2.
expression phenotype of Na,K-ATPase isozymes, which may
be similar to that of CRC cells. Table 2 summarizes the cell-
specific Na,K-ATPase subunit-isoforms expression and Table 3
highlights the possible cell-specific Na,K-ATPase isozymes
present in healthy colon, colorectal cancer, healthy liver and
metastasized liver.
Based on the results presented we propose that the
predominating isozymes in tumor cells from the colon and
metastases in the liver are α1β1 and α3β1. The α3β1 isozyme of
Na,K-ATPase is only present in livermetastases but not in healthy
liver, thus, the α3β1 isozyme could serve as a novel exploratory
biomarker of CRCmetastatic cells in liver. Further studies should
be carried out to test the utility of this observation.
Subunits of Na,K-ATPase have the ability to form functional
isoenzymes by a promiscuous association of α and β isoforms
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FIGURE 6 | Double immunofluorescence localization of Na,K-ATPase
α3 and β1 isoform in liver metastasis. (A) α3 isoform is located at a
peri-nuclear position and all-over the cytoplasm. (B) β1 isoform is mainly
located at the plasma membrane of metastases cells and in nuclear envelope.
(C) Merge.
TABLE 2 | Cell-specific Na,K-ATPase subunit-isoform expression in
normal colon, colorectal cancer, normal liver, and metastasized liver.
α1 α3 β1 β2
Normal colon
Epithelial cells (Mucosae) +++ +++ +++ +
Mesenchymal cells (Submucosae) + + + +
Smooth muscle cells (Muscularis mucosae) ? ? ? ?
Neurons (Myenteric plexus) ? + +++ ?
Glia cells (Myenteric plexus) ? ? +++ +++
Smooth muscle cells (Muscularis propia) ? + − +
Colorectal cancer
Tumor cells +++ +++ +++ −
Mesenchymal cells (not immune system cells) + +++ − +
Immune system cells ? +++ ? ?
Endothelial cells ? +++ − ?
Epithelial cells (Mucosae) +++* +++ +++ −
Normal liver
Hepatocytes +++ − +++ +
Ephitelial cells (bile duct) +++ − + +
Endothelial cells − − − −
Mesenchymal cells (connective tissue) − − − +
Metastasized liver
Tumor cells +++ +++ + −
Hepatocytes ? + ? −*
Epithelial cells (Bile duct) +++ ? ? ?
Mesenchymal cells (connective tissue) − + − −
Immune system cells − +++ ? ?
+ + +, indicates a high staining level; +, indicates low staining level; −, indicates no
staining detected; and ?, indicates indeterminate staining, according to our observations.
*Data not shown.
to confer significantly different kinetic and biological
properties. The apparent affinities for cations and ouabain
have been determined by expressing recombinant enzymes in
heterologous systems. Affinities of human isozymes expressed
in Xenopus laevis oocytes are α1β1>α2β1>α3β1 for Na+ and
α3β1=α1β1>α1β3>α1β2>α2β1>α3β3>α3β2>α2β3>α2β2 for
K+ (Blanco andMercer, 1998; Crambert et al., 2000). Tumor cells
and metastatic cells have isozymes with highest and lowest Na+
affinity and surrounding mesenchymal cells possess isozymes
with medium range affinity. Regarding K+ affinity, tumor and
metastasis cells possess Na,K-ATPase isozymes of high K+
affinity and mesenchymal cells low K+ affinity. These are the
isozyme combinations that permit an optimal performance
of the enzymes involved in protein synthesis and transfer of
phosphor groups (Glynn, 1985) processes both involved in
carcinogenesis.
Another objective of this study was to correlate the mitotic
index related to the expression of isoforms by co-localization of
those along with PCNA, the clamp subunit of DNA polymerase
δ marker of cell proliferation (Kubben et al., 1994; Bleau et al.,
2014) and carried out further analysis by confocal microscopy.
Figure 3 shows cells expressing the α3 and β1 isoforms in CRC
tumor cells, in which no correlation was seen between sodium
pump isoforms and PCNA protein expression, that is, high
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TABLE 3 | Possible cell-specific Na, K-ATPase isozymes present in normal
colon, colorectal cancer, normal liver, and metastasized liver.
α1β1 α1β2 α3β1 α3β2
NORMAL COLON
Epithelial cells (Mucosae) +++ + +++ +
Mesenchymal cells (Submucosae) + + + +
Smooth muscle cells (Muscularis mucosae) ? ? ? ?
Neurons (Myenteric plexus) ? ? +++ ?
Glia cells (Myenteric plexus) ? ? ? ?
Smooth muscle cells (Muscularis propia) – ? – +++
COLORECTAL CANCER
Tumor cells +++ – +++ –
Mesenchymal cells (Not immune system cells) – + – +++
Immune system cells ? ? ? ?
Endothelial cells – ? – ?
Epithelial cells (Mucosae) +++ – +++ –
NORMAL LIVER
Hepatocytes +++ + – –
Ephitelial cells (Bile duct) +++ +++ – –
Endothelial cells – – – –
Mesenchymal cells (Connective tissue) – – – –
METASTIZED LIVER
Tumor cells +++ – +++ –
Hepatocytes ? – ? –
Epithelial cells (Bile duct) ? ? ? ?
Mesenchymal cells (Connective tissue) – – – –
Immune system cells – – ? ?
+ + +, Indicates a possible high level of the isozyme; +, indicates a possible low
presence of the isozyme; –, indicates no possibility; and ?, indicates indeterminate
staining, according to our observations.
expression of PCNA can be found in cells with either, high or
low, expression level of α3 or β1 and vice versa.
Hideki Sakai and co-workers (Sakai et al., 2004) used western
blotting to demonstrate a decrease in α1 isoform expression in
CRC and, inversely, an increase in the α3 isoform compared
to the accompanying healthy mucosae. In addition they did
not observe a significant expression level of Na,K-ATPase α2
isoform either in the CRC or in the accompanying healthy
mucosae. Our study, confirms their observations. In addition, in
recent studies of hepatocellular carcinoma, a significantly higher
α3 level expression was shown in western blots compared to
the accompanying non-tumor tissues, whereas no significant
increases in expression of α1 and α2 proteins was observed
(Shibuya et al., 2010).
Recently, it has been suggested that the cellular distribution
and expression of Na,K-ATPase α3 isoform affects the anti-
proliferative effects of oleandrin, a cardiac glycoside that inhibits
the Na,K-ATPase (Yang et al., 2014). These authors demonstrated
that healthy, as opposed to neoplastic colonic and lung tissues,
exhibit different distributions of the α3 isoform. While the
α3 isoform was predominantly located in the cytoplasmic
membrane in healthy colon and lung, the distribution of this
isoform was shifted to a predominantly peri-nuclear location
in tumors. These observations have been corroborated by
our laboratory. Furthermore, our results showed a subcellular
location shift for the α1 isoform, which was mainly located at
the basolateral side of the plasma membrane of healthy colonic
epithelial cells, shifting to a peri-nuclear position in CRC tumor
cells.
The α1 and α3 subunit isoforms were detected in all cells
lining the colonic crypts. These isoforms were not only expressed
in epithelial cells in healthy colon mucosae, but they were also
detected in mesenchymal cells from the lamina propria. The α3
isoform presents a high expression level in neurons of the central
nervous system (Hieber et al., 1991; McGrail et al., 1991). The
present study shows specific staining for α3 in neurons from
myenteric plexus.
Regarding the β subunit, it has been reported that expression
of both the β1 and β2 mRNAs were decreased in renal,
lung and hepatocellular carcinomas (Akopyanz et al., 1991),
and that expression levels of the corresponding proteins
was decreased in human clear cell renal cell carcinoma
(Rajasekaran et al., 1999) and bladder carcinoma (Espineda
et al., 2004). Previous work from our laboratory (Avila
et al., 1997) reported, by western blot technique, that gastric
and colon adenocarcinoma showed opposite patterns of β1
isoform expression. While gastric adenocarcinomas showed
lower expression levels of β1 than the healthy tissue, colonic
adenocarcinomas showed higher expression of this isoform
compared to healthy surrounding tissue. In addition, the β2
isoform was neither detected in healthy colon, nor in stomach
adenocarcinomas. In the present immunohistochemical study,
we detected the β1 and β2 isoforms at the baso-lateral side of
the plasma membrane in the healthy colon mucosae, but only
β1 was found in CRC samples. Which, in a certain manner,
resembles our previous findings in Na,K-ATPase in dog and
rat prostate cancer where we found a downregulation and a
reduced expression of sodium pump (Mobasheri et al., 2000,
2003a,b,c).
Na,K-ATPase β1 and β2 isoforms were detected in the
myenteric plexus of healthy colon tissue. It is well-established that
the β2 isoform of Na,K-ATPase, is an adhesion molecule on glia
(AMOG) (Antonicek et al., 1987; Gloor et al., 1990).
In tumor samples, the β1 isoform presented a less defined
pattern of expression. This isoform was detected in some tumor
cells but not all, also the subcellular location differed among
cells within a given adenocarcinomatous area, while some tumor
cells where immunopositive for β1 at the cytoplasmic membrane
location (Figure 2D) other cells presented immunostaining in a
peri-nuclear position (Figure 2C).
Research by Rajasekaran and colleagues reported that Na,K-
ATPase β subunit is required for epithelial polarization,
suppression of invasion, and cell motility (Rajasekaran et al.,
2001b), not only presence of Na,K-ATPase in the cell membrane
but also Na,K-ATPase activity was important to form proper tight
junctions, desmosomes, and induction of polarity in epithelial
cells (Rajasekaran et al., 2001b). Further studies suggested that
the transcription factor Snail might be repressing the β1 isoform
and E-cadherin expression in carcinomas, associating these
events to epithelial-mesenchymal transition (EMT) (Espineda
et al., 2004).
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Taken together, these studies and our results indicate
that the level of expression and the location of the β
subunit in epithelial cells are important for maintaining their
well-differentiated phenotype, which disappears during cancer
progression. Research published by our group on sodium pump
isoform expression levels in stem cells has confirmed that
adipose-derivedmesenchymal stem cells express all knownNa,K-
ATPase isoforms, but some of these genes are turned off along
differentiation (Acosta et al., 2011). In CRC cells or its metastases
in liver we have never seen expression of all isoforms, rather, we
have detected the expression signatures specified in Table 2.
Regarding liver metastases, to our knowledge, there have
not been any reported studies in reference to Na,K-ATPase
isoforms in liver metastasis. In this study the α1 isoform
was detected in metastatic tumor cell niches within the liver,
exhibiting a cytoplasmic subcellular localization in some cells
and a membrane localization in others. The α3 isoform,
however, was mainly detected at a peri-nuclear location and
was more diffusely expressed across the cytoplasm of tumor
metastatic cells. The healthy hepatic tissue presented the α1
isoform at the cytoplasmic membrane where it may establish the
functional heterodimer with a β1 isoform and/or β2 isoform.
Our observations of the subcellular localization of the α1 isoform
are consistent with the first reported immunolocalization of
this subunit in hepatocytes of healthy liver tissue (Sztul et al.,
1987). However, in healthy liver tissue, the α3 isoform was not
detected.
The β2 isoform was detected both at a more peri-nuclear
position in some hepatocytes and throughout the cytoplasm in
others, but not at the cytoplasmic membrane. The reason for this
is unclear at present. It is possible that β2 isoform performs other
moonlighting protein functions in hepatocytes. In metastasized
liver, we detected the β1 isoform in disordered and semi-necrotic
tumor tissue. However, β2 isoform was not detected in liver
metastases. This may be related to the fact that these metastatic
cells arise from CRC tumor cells, which did neither express β2
isoform or at very insignificant levels. Interestingly, apparently
in healthy hepatic tissue surrounding the metastatic zone, the
hepatocytes expressed the α3 isoform, a phenotype not detected
in healthy hepatocytes from non-CRC patient according to our
results. It might be possible that the CRC and the FOLFOX-
CT affecting this patient could be influencing these hepatocytes
driving them to express other genes, ATP1A3 in this case.
The high levels of peri-nuclear and cytoplasmic α3 isoform
in liver metastatic cells is potentially indicative of other
moonlighting functions of this isoform besides ion transport
(Jeffery, 2014; Magpusao et al., 2015; Min et al., 2015). In
addition, the α3β1 isozyme may have utility as a novel
exploratory biomarker for metastases cells. However, further
studies need to be performed in order to confirm both, the
moonlighting and biomarker assessments.
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